{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:46:46Z","timestamp":1792061206232,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Development Plan of Henan Provincial Department of Science and Technology","award":["242102310094"],"award-info":[{"award-number":["242102310094"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-62456-9","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:25:01Z","timestamp":1784042701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Induction of paraptotic cell death in breast cancer cells by an iron chelator involved activation of UPR\/MAPK pathway and inactivation of PI3K\/AKT\/mTOR"],"prefix":"10.1038","volume":"16","author":[{"given":"Lei","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-5843","authenticated-orcid":false,"given":"Changzheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"62456_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"62456_CR2","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","volume":"24","author":"A Prat","year":"2015","unstructured":"Prat, A. et al. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast 24 (2), S26\u201335 (2015).","journal-title":"Breast"},{"issue":"Suppl 3","key":"62456_CR3","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0960-9776(11)70293-4","volume":"20","author":"M Giuliano","year":"2011","unstructured":"Giuliano, M. et al. Biological mechanisms and clinical implications of endocrine resistance in breast cancer. Breast 20 (Suppl 3), S42\u2013S49 (2011).","journal-title":"Breast"},{"key":"62456_CR4","first-page":"1071","volume":"34","author":"S Byler","year":"2014","unstructured":"Byler, S. et al. Genetic and epigenetic aspects of breast cancer progression and therapy. Anticancer Res. 34, 1071\u20131077 (2014).","journal-title":"Anticancer Res."},{"key":"62456_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2325\/jbcs.12.211","volume":"12","author":"A Luque-bolivar","year":"2020","unstructured":"Luque-bolivar, A. et al. Resistance and overcoming resistance in breast cancer. Breast Cancer. 12, 211\u2013229 (2020).","journal-title":"Breast Cancer"},{"key":"62456_CR6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/antiox11010117","volume":"11","author":"PL Nguyen","year":"2022","unstructured":"Nguyen, P. L., Lee, C. H., Lee, H. & Cho, J. Induction of paraptotic cell death in breast cancer cells by a novel pyrazolo [3,4-h]quinoline Derivative through ROS Production and Endoplasmic Reticulum Stress. Antioxidants 11, 117 (2022).","journal-title":"Antioxidants"},{"key":"62456_CR7","doi-asserted-by":"crossref","first-page":"9566","DOI":"10.1038\/s41598-018-27724-3","volume":"8","author":"H Han","year":"2018","unstructured":"Han, H. et al. Chalcomoracin is a potent anticancer agent acting through triggering Oxidative stress via a mitophagy- and paraptosis dependent mechanism. Sci. Rep. 8, 9566 (2018).","journal-title":"Sci. Rep."},{"key":"62456_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.abb.2007.03.034","volume":"462","author":"I Kim","year":"2007","unstructured":"Kim, I., Rodriguezenriquez, S. & Lemasters, J. Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 462, 245\u2013253 (2007).","journal-title":"Arch. Biochem. Biophys."},{"key":"62456_CR9","first-page":"3","volume":"146","author":"G Majno","year":"1995","unstructured":"Majno, G. & Joris, I. Apoptosis, oncosis, and necrosis. Overview of cell death. Am. J. Pathol. 146, 3\u201315 (1995).","journal-title":"Am. J. Pathol."},{"key":"62456_CR10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cub.2009.11.020","volume":"20","author":"O Florey","year":"2010","unstructured":"Florey, O., Krajcovic, M., Qiang, S., Overholtzer, M. & Entosis Curr. Biol. 20, 88\u201389 (2010).","journal-title":"Curr. Biol."},{"key":"62456_CR11","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1242\/jcs.00994","volume":"117","author":"Y Wang","year":"2004","unstructured":"Wang, Y. et al. An alternative form of paraptosis-like cell death triggered by TAJ\/TROY is enhanced by PDCD5 overexpression. J. Cell. Sci. 117, 1525\u20131532 (2004).","journal-title":"J. Cell. Sci."},{"key":"62456_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm3028","volume":"12","author":"RJ Youle","year":"2011","unstructured":"Youle, R. J. & Narendra, D. P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell. Bio. 12, 9\u201314 (2011).","journal-title":"Nat. Rev. Mol. Cell. Bio"},{"issue":"26","key":"62456_CR13","doi-asserted-by":"crossref","first-page":"14376","DOI":"10.1073\/pnas.97.26.14376","volume":"97","author":"S Sperandio","year":"2000","unstructured":"Sperandio, S., De Belle, I. & Bredesen, D. E. An alternative, non-apoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA. 97 (26), 14376\u201314381 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"62456_CR14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.freeradbiomed.2009.12.016","volume":"48","author":"MJ Yoon","year":"2010","unstructured":"Yoon, M. J. et al. Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells. Free Radic Biol. Med. 48 (5), 713\u2013726 (2010).","journal-title":"Free Radic Biol. Med."},{"issue":"3","key":"62456_CR15","first-page":"195","volume":"181","author":"PG Clarke","year":"1990","unstructured":"Clarke, P. G. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryols (Berl. 181 (3), 195\u2013213 (1990).","journal-title":"Anat Embryols (Berl"},{"key":"62456_CR16","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/sj.cdd.4401465","volume":"11","author":"S Sperandio","year":"2004","unstructured":"Sperandio, S. et al. Paraptosis: Mediation by MAP kinases and inhibition by AIP-1\/Alix. Cell. Death Differ. 11, 1066\u20131075 (2004).","journal-title":"Cell. Death Differ."},{"issue":"17","key":"62456_CR17","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1021\/acs.biochem.4c00085","volume":"63","author":"M Nii","year":"2024","unstructured":"Nii, M. et al. Induction of paraptotic cell death in cancer cells by triptycene-peptide hybrids and the revised mechanism of paraptosis II. Biochemistry 63 (17), 2111\u20132130 (2024).","journal-title":"Biochemistry"},{"issue":"4","key":"62456_CR18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ceb.2004.06.012","volume":"16","author":"B Kleizen","year":"2004","unstructured":"Kleizen, B. & Braakman, I. Protein folding and quality control in the endoplasmic reticulum. Curr. Opin. Cell. Biol. 16 (4), 343\u2013349 (2004).","journal-title":"Curr. Opin. Cell. Biol."},{"issue":"5","key":"62456_CR19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0143416002001823","volume":"32","author":"MJ Berridge","year":"2002","unstructured":"Berridge, M. J. The endoplasmic reticulum: a multifunctional signaling organelle. Cell. Calcium. 32 (5), 235\u2013249 (2002).","journal-title":"Cell. Calcium"},{"key":"62456_CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biochi.2015.02.006","volume":"114","author":"F Wang","year":"2015","unstructured":"Wang, F. et al. Ubiquitination of newly synthesized proteins in ribosomes. Biochimie 114, 127\u2013133 (2015).","journal-title":"Biochimie"},{"issue":"3","key":"62456_CR21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biocel.2005.09.018","volume":"38","author":"SB Cullinan","year":"2006","unstructured":"Cullinan, S. B. & Diehl, J. A. Coordination of ER and oxidative stress signaling: the PERK\/Nrf2 signaling pathway. Int. J. Biochem. Cell. Biol. 38 (3), 317\u2013332 (2006).","journal-title":"Int. J. Biochem. Cell. Biol."},{"issue":"3","key":"62456_CR22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/ijms21031102","volume":"21","author":"S Lee","year":"2020","unstructured":"Lee, S., Rauch, J. & Kolch, W. Targeting MAPK signaling in cancer: Mechanisms of drug resistance and sensitivity. Int. J. Mol. Sci. 21 (3), 1102 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"62456_CR23","doi-asserted-by":"crossref","unstructured":"Chang, L. C., Chiang, S. K., Chen, S. E. & Hung, M. C. Exploring paraptosis as a therapeutic approach in cancer treatment. J Biomed. Sci 31(1),101 (2024).","DOI":"10.1186\/s12929-024-01089-4"},{"key":"62456_CR24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","volume":"53","author":"MM Gottesman","year":"2002","unstructured":"Gottesman, M. M. Mechanisms of cancer drug resistance. Annu. Rev. Med. 53, 615\u2013627 (2002).","journal-title":"Annu. Rev. Med."},{"key":"62456_CR25","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1038\/cddis.2013.85","volume":"4","author":"M Bury","year":"2013","unstructured":"Bury, M. et al. Ophiobolin-A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity. Cell. Death Dis. 4, e561 (2013).","journal-title":"Cell. Death Dis."},{"issue":"16","key":"62456_CR26","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1021\/ja109413c","volume":"133","author":"S Tardito","year":"2011","unstructured":"Tardito, S. et al. Copper binding agents acting as copper ionophores lead to caspase inhibition and paraptotic cell death in human cancer cells. J. Am. Chem. Soc. 133 (16), 6235\u20136242 (2011).","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"62456_CR27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/jm701146c","volume":"51","author":"C Marzano","year":"2008","unstructured":"Marzano, C. et al. In vitro antitumor activity of water soluble copper (I) complexes bearing the tris (hydroxymethyl) phosphine ligand. J. Med. Chem. 51 (4), 798\u2013808 (2008).","journal-title":"J. Med. Chem."},{"issue":"10","key":"62456_CR28","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1039\/C7SC02205K","volume":"8","author":"C Li","year":"2017","unstructured":"Li, C. et al. Cytotoxic (salen) ruthenium (III) anticancer complexes exhibit different modes of cell death owing to axial ligands. Chem. Sci. 8 (10), 6865\u20136870 (2017).","journal-title":"Chem. Sci."},{"issue":"9","key":"62456_CR29","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1039\/C6SC00387G","volume":"7","author":"V Pierroz","year":"2016","unstructured":"Pierroz, V. et al. Dual mode of cell death upon photoirradiation of a Ru II polypyridyl complex during interphase or mitosis. Chem. Sci. 7 (9), 6115\u20136124 (2016).","journal-title":"Chem. Sci."},{"key":"62456_CR30","doi-asserted-by":"crossref","unstructured":"Solovieva, M. et al. Disulfiram oxy-derivatives induce entosis or paraptosis-like death in breast cancer MCF-7 cells depending on the duration of treatment. Biochim Biophys. Acta Gen. Subj 1866(9),130184 (2022).","DOI":"10.1016\/j.bbagen.2022.130184"},{"key":"62456_CR31","doi-asserted-by":"crossref","first-page":"115874","DOI":"10.1016\/j.bcp.2023.115874","volume":"218","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. Ferritinophagy-mediated apoptosis and paraptosis induction involved the MAPK and PI3K\/AKT pathways in the mechanism of iron chelation. Biochem. Pharmacol. 218, 115874 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"62456_CR32","doi-asserted-by":"crossref","unstructured":"Guo, X. et al. Di-2-pyridylhydrazone dithiocarbamate butyric acid ester exerted its proliferative inhibition against gastric cell via ROS-mediated apoptosis and autophagy. Oxid Med Cell Longev. 2018, 4950705 (2018).","DOI":"10.1155\/2018\/4950705"},{"key":"62456_CR33","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. DpdtbA-induced growth inhibition in human esophageal cancer cells involves inactivation of the p53\/EGFR\/AKT pathway. Oxid Med Cell Longev. 2019, 5414670(2019).","DOI":"10.1155\/2019\/5414670"},{"issue":"1","key":"62456_CR34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.4838","volume":"256","author":"SH Kaufmann","year":"2000","unstructured":"Kaufmann, S. H. & Earnshaw, W. C. Induction of apoptosis by cancer chemotherapy. Exp. Cell. Res. 256 (1), 42\u201349 (2000).","journal-title":"Exp. Cell. Res."},{"issue":"3","key":"62456_CR35","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1038\/cddis.2013.85","volume":"4","author":"M Bury","year":"2013","unstructured":"Bury, M. et al. Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity. Cell. Death Dis. 4 (3), e561 (2013).","journal-title":"Cell. Death Dis."},{"key":"62456_CR36","doi-asserted-by":"crossref","first-page":"C1082","DOI":"10.1152\/ajpcell.00217.2006","volume":"291","author":"C Camello-Almaraz","year":"2006","unstructured":"Camello-Almaraz, C., Gomez-Pinilla, P. J., Pozo, M. J. & Camello, P. J. Mitochondrial reactive oxygen species and Ca2\u2009+\u2009signaling. Am. J. Physiol. Cell. Physiol. 291, C1082\u2013C1088 (2006).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"62456_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrm3412","volume":"13","author":"R Rizzuto","year":"2012","unstructured":"Rizzuto, R., De Stefani, D., Raffaello, A. & Mammucari, C. Mitochondria as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell. Biol. 13, 566\u2013578 (2012).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"1","key":"62456_CR38","doi-asserted-by":"crossref","first-page":"e21200","DOI":"10.1096\/fj.202001106RRR","volume":"35","author":"YH Lai","year":"2021","unstructured":"Lai, Y. H. et al. Thrombospondin 1-induced exosomal proteins attenuate hypoxia-induced paraptosis in corneal epithelial cells and promote wound healing. FASEB J. 35 (1), e21200 (2021).","journal-title":"FASEB J."},{"key":"62456_CR39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2012.05.018","volume":"324","author":"MJ Yoon","year":"2012","unstructured":"Yoon, M. J. et al. Simultaneous mitochondrial Ca(2+) overload and proteasomal inhibition are responsible for the induction of paraptosis in malignant breast cancer cells. Cancer Lett. 324, 197\u2013209 (2012).","journal-title":"Cancer Lett."},{"key":"62456_CR40","doi-asserted-by":"crossref","unstructured":"Fontana, F. et al. The emerging role of paraptosis in tumor cell biology: perspectives for cancer prevention and therapy with natural compounds. Biochim Biophys. Acta Rev. Cancer 1873,188338 (2020).","DOI":"10.1016\/j.bbcan.2020.188338"},{"key":"62456_CR41","doi-asserted-by":"crossref","first-page":"109203","DOI":"10.1016\/j.biopha.2019.109203","volume":"118","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Small-molecule compounds target paraptosis to improve cancer therapy. Biomed. Pharmacother. 118, 109203 (2019).","journal-title":"Biomed. Pharmacother"},{"key":"62456_CR42","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/jcm8050624","volume":"8","author":"PG Santamar\u00eda","year":"2019","unstructured":"Santamar\u00eda, P. G. et al. UPR: An upstream signal to EMT induction in cancer. J. Clin. Med. 8, 624 (2019).","journal-title":"J. Clin. Med."},{"key":"62456_CR43","doi-asserted-by":"publisher","first-page":"103120","DOI":"10.1016\/j.jri.2020.103120","volume":"139","author":"F Liu","year":"2020","unstructured":"Liu, F., Chang, L. & Hu, J. Activating transcription factor 6 regulated cell growth and migration and inhibited cell apoptosis and autophagy via the MAPK pathway in cervical cancer. J. Reprod. Immunol. 139, 103120. https:\/\/doi.org\/10.1016\/j.jri.2020.103120 (2020).","journal-title":"J. Reprod. Immunol."},{"key":"62456_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrm2199","volume":"8","author":"D Ron","year":"2007","unstructured":"Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell. Biol. 8, 519\u2013529 (2007).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"62456_CR45","doi-asserted-by":"crossref","first-page":"665647","DOI":"10.3389\/fmed.2021.665647","volume":"8","author":"L Mercurio","year":"2021","unstructured":"Mercurio, L., Albanesi, C. & Madonna, S. Recent updates on the involvement of PI3K\/AKT\/mTOR molecular cascade in the pathogenesis of hyperproliferative skin disorders. Front Med (Lausanne). 8, 665647 (2021).","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"62456_CR46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/2211738507666190122111224","volume":"7","author":"FA Fisusi","year":"2019","unstructured":"Fisusi, F. A. & Akala, E. O. Drug combinations in breast cancer therapy. Pharm. Nanotechnol. 7 (1), 3\u201323 (2019).","journal-title":"Pharm. Nanotechnol"},{"issue":"5","key":"62456_CR47","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","volume":"14","author":"MCU Cheang","year":"2008","unstructured":"Cheang, M. C. U. et al. Basal-like breast cancer defined by the five biomarkers has a superior prognostic value than the triple-negative phenotype. Clin. Cancer Res. 14 (5), 1368\u20131376 (2008).","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"62456_CR48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1042\/BST20191055","volume":"48","author":"S Lev","year":"2020","unstructured":"Lev, S. Targeted therapy and drug resistance in triple-negative breast cancer: The EGFR axis. Biochem. Soc. Trans. 48 (2), 657\u2013665 (2020).","journal-title":"Biochem. Soc. Trans."},{"key":"62456_CR49","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","volume":"35","author":"RM Mohammad","year":"2015","unstructured":"Mohammad, R. M. et al. Broadly targeting apoptosis resistance in cancer. Semin Cancer Biol. 35, S78 (2015).","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"62456_CR50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.yexcr.2018.02.018","volume":"364","author":"D Nedungadi","year":"2018","unstructured":"Nedungadi, D. et al. 6-Shogaol induces caspase-independent paraptosis in cancer cells via proteasomal inhibition. Exp. Cell. Res. 364 (2), 243\u2013251 (2018).","journal-title":"Exp. Cell. Res."},{"issue":"2","key":"62456_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"T Vanden Berghe","year":"2014","unstructured":"Vanden Berghe, T. et al. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell. Biol. 15 (2), 135\u2013147 (2014).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"62456_CR52","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.12659\/MSM.902522","volume":"23","author":"B Wang","year":"2017","unstructured":"Wang, B., Zhou, X., Wang, Y. & Li, R. Trifluoperazine inhibits mesangial cell proliferation by arresting cell cycle-dependent mechanisms. Med. Sci. Monit. 23, 3461\u20133469 (2017).","journal-title":"Med. Sci. Monit."},{"issue":"9","key":"62456_CR53","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1158\/1078-0432.CCR-04-2223","volume":"11","author":"LE Broker","year":"2005","unstructured":"Broker, L. E., Kruyt, F. A. & Giaccone, G. Cell death independent of caspases: A review. Clin. Cancer Res. 11 (9), 3155\u20133162 (2005).","journal-title":"Clin. Cancer Res."},{"issue":"5\u20136","key":"62456_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10495-021-01668-y","volume":"26","author":"M Raimondi","year":"2021","unstructured":"Raimondi, M. et al. Ca2+ overload and ROS-associated mitochondrial dysfunction contribute to \u03b4-tocotrienol-mediated paraptosis in melanoma cells. Apoptosis 26 (5\u20136), 277\u2013292 (2021).","journal-title":"Apoptosis"},{"key":"62456_CR55","doi-asserted-by":"publisher","first-page":"102979","DOI":"10.1016\/j.redox.2023.102979","volume":"69","author":"X Li","year":"2024","unstructured":"Li, X. et al. Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE\/PKC\/NOX axis. Redox Biol. 69, 102979. https:\/\/doi.org\/10.1016\/j.redox.2023.102979 (2024).","journal-title":"Redox Biol."},{"key":"62456_CR56","doi-asserted-by":"crossref","unstructured":"Guan, D. et al. Ferritinophagy-mediated ferroptosis and activation of Keap1\/Nrf2\/HO-1 pathway were conducive to EMT inhibition of gastric cancer cells in action of 2,2\u2019-di-pyridineketone hydrazone dithiocarbamate butyric acid ester. Oxid Med Cell Longev 2022. 3920664(2022).","DOI":"10.1155\/2022\/3920664"},{"key":"62456_CR57","doi-asserted-by":"crossref","first-page":"C221","DOI":"10.1152\/ajpcell.1999.276.1.C221","volume":"276","author":"JA Maloney","year":"1999","unstructured":"Maloney, J. A. et al. Activation of ERK by Ca2+ store depletion in rat liver epithelial cells. Am. J. Physiol. 276, C221\u2013C230 (1999).","journal-title":"Am. J. Physiol."},{"key":"62456_CR58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-020-00949-4","volume":"13","author":"J Yuan","year":"2020","unstructured":"Yuan, J. et al. MAPK and AMPK signaling: Interplay and implications in targeted cancer therapy. J. Hematol. Oncol. 13, 113 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"62456_CR59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.18632\/oncotarget.240","volume":"2","author":"WH Chappell","year":"2011","unstructured":"Chappell, W. H. et al. Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR inhibitors: Rationale and importance to inhibiting these pathways in human health. Oncotarget 2, 135\u2013164 (2011).","journal-title":"Oncotarget"},{"key":"62456_CR60","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner, E. F. & Nebreda, \u00c1. R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer. 9, 537\u2013549 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"62456_CR61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jcp.10049","volume":"190","author":"JY Kim","year":"2002","unstructured":"Kim, J. Y. et al. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J. Cell. Physiol. 190, 29\u201337 (2002).","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"62456_CR62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41392-022-01131-7","volume":"7","author":"GN Li","year":"2022","unstructured":"Li, G. N. et al. Elaiophylin triggers paraptosis and preferentially kills drug-resistant ovarian cancer cells by inducing MAPK hyperactivation. Signal. Transduct. Target. Ther. 7 (1), 317 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"10","key":"62456_CR63","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.bbamcr.2014.01.009","volume":"1843","author":"NJ Darling","year":"2014","unstructured":"Darling, N. J. & Cook, S. J. Role of MAPK signalling pathways in response to endoplasmic reticulum stress. Biochim. Biophys. Acta. 1843 (10), 2150\u20132163 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"62456_CR64","first-page":"20","volume":"70","author":"A Carreras-Sureda","year":"2017","unstructured":"Carreras-Sureda, A., Pih\u00e1n, P. & Hetz, C. Calcium signaling at the endoplasmic reticulum: fine-tuning stress responses. Cell. Calcium. 70, 20\u201331 (2017).","journal-title":"Cell. Calcium"},{"key":"62456_CR65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","volume":"43","author":"C He","year":"2009","unstructured":"He, C. & Klionsky, D. J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43, 67\u201393 (2009).","journal-title":"Annu. Rev. Genet."},{"key":"62456_CR66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2015.03.003","volume":"33","author":"K Mnich","year":"2015","unstructured":"Mnich, K. et al. Controlling the unfolded protein response-mediated life and death decisions in cancer. Semin Cancer Biol. 33, 57\u201366 (2015).","journal-title":"Semin Cancer Biol."},{"key":"62456_CR67","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20050374","volume":"393","author":"SH Liang","year":"2006","unstructured":"Liang, S. H. et al. PERK (eIF2alpha kinase) is required to activate stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis. Biochem. J. 393, 201\u2013209 (2006).","journal-title":"Biochem. J."},{"issue":"5","key":"62456_CR68","doi-asserted-by":"crossref","first-page":"e0007922","DOI":"10.1128\/iai.00079-22","volume":"90","author":"L Chen","year":"2022","unstructured":"Chen, L. et al. Chlamydia psittaci induces autophagy in human bronchial epithelial cells via PERK and IRE1a, but not the ATF6 pathway. Infect. Immun. 90 (5), e0007922. 10.1128\/ (2022). iai.00079\u2009\u2013\u200922.","journal-title":"Infect. Immun."},{"key":"62456_CR69","doi-asserted-by":"publisher","unstructured":"Wang, S. W. et al. TUDCA inhibits EV71 replication by regulating the ER stress signaling pathway and suppressing autophagy. Diagn Microbiol Infect Dis. 110(4), 116500 (2024). https:\/\/doi.org\/10.1016\/j.diagmicrobio. 2024. 116500.","DOI":"10.1016\/j.diagmicrobio"},{"issue":"1","key":"62456_CR70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/156800908783497140","volume":"8","author":"E Tokunaga","year":"2008","unstructured":"Tokunaga, E. et al. Deregulation of the Akt pathway in human cancer. Curr. Cancer Drug Targets. 8 (1), 27\u201336 (2008).","journal-title":"Curr. Cancer Drug Targets"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62456-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62456-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62456-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:06:56Z","timestamp":1792058816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62456-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["62456"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-62456-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"32321"}}